Chairman and CEO, DaVita Inc.
Kent Thiry is chairman and CEO of DaVita, a Fortune 200 company with 75,000 teammates and approximately $14 billion in revenue. The company operates in 11 countries, delivering clinically differentiated health care to nearly 2 million patients.
DaVita has been the subject of leadership and culture case studies written by both Harvard and Stanford universities, and taught in many other schools and programs. Thiry sits on the Harvard Business School’s advisory board and is regularly invited to speak on leadership and culture at top business schools, companies and not-for-profit leadership groups.
In 2016, Thiry founded Let Colorado Vote, a group that has passed four ballot initiatives in the last three years. One re-established the presidential primary in Colorado, a second opened its primaries to independent voters and the most recent two reformed redistricting practices. In 2018, he also founded a statewide CEO group, Colorado Thrives, which focuses on advancing the quality of life for all Coloradans. He also co-founded both The Aspen Group, with former U.S. senators Bill Frist and Tom Daschle, and COIN, The Colorado Innovation Network, with former governor John Hickenlooper and several others. He also is on the advisory board of NatureVest, a unit of The Nature Conservancy.
Prior to joining DaVita, Thiry served in several roles, including chairman and CEO of Vivra Specialty Partners, a specialty health care company; CEO of Vivra, a New York Stock Exchange-listed health care service company; and partner at Bain & Company. Prior board seats include the chairman of Oxford Health Plans as well as The Trust for Public Land.
Kent earned his B.A. in political science, with distinction, from Stanford University, where he also was elected to Phi Beta Kappa, in 1978. He earned his M.B.A., with honors, from Harvard Business School in 1983, where he was also elected to the Century Club.
In 2013, Thiry received the Woodrow Wilson Award for Corporate Citizenship, and in 2016, he received the International Bridge Builders Award from the University of Denver.
Thiry is also an enthusiastic, but only modestly talented, mountain biker!
Chief Compliance Officer, AMGEN
Cynthia M. Patton serves as senior vice president and chief compliance officer, responsible for Amgen’s global privacy and compliance organization. Patton joined Amgen in 2005 and most recently was a vice president in the Amgen law department, with responsibility for commercial legal activities in the United States. Prior to that position, she served as the lead commercial lawyer for both the oncology and inflammation business units.
Before joining Amgen, Patton spent seven years as general counsel of SCAN Health Plan, a California health maintenance organization (HMO). Prior to SCAN, she served as assistant general counsel of UniHealth Foundation and as a staff attorney in the Division of Enforcement at the U.S. Securities and Exchange Commission. She began her legal career at Atlanta-based Alston & Bird in 1986 before moving to Los Angeles to work in law firms specializing in health care corporate and securities law.
Patton previously served as a board member of Watts Healthcare Corporation and Eisner Pediatric & Family Medical Center. Currently, she is the chair of the Amgen Foundation. She is also a member of the board of trustees of Wildwood School, a board member at the Los Angeles Music Center and a board member at Martin Luther King, Jr. Community Hospital in Los Angeles.
Patton received her Juris Doctor from The National Law Center at George Washington University and her bachelor’s degree from Vassar College.
Susan M. Love, M.D., MBA
Chief Visionary Officer, Dr. Susan Love Research Foundation
Susan M. Love, M.D., MBA, has dedicated her professional life to the eradication of breast cancer. As chief visionary officer of the Dr. Susan Love Research Foundation, Dr. Love oversees an innovative research program centered on breast cancer cause and prevention. She is also a clinical professor of surgery at UCLA’s David Geffen School of Medicine. One of the founders of the National Breast Cancer Coalition, she is well known as a trusted guide to women worldwide through the foundation’s ImPatient Science® education program and her books, including Dr. Susan Love’s Breast Book, now in its sixth edition. The foundation’s recent groundbreaking initiatives include the Army of Women®, developed to partner women and scientists to accelerate translational research, and the Health of Women (HOW) Study®, an online cohort study aimed at identifying the cause of breast cancer. Among the foundation’s collaborative research projects are the development of an National Institutes of Health-funded self-reading ultrasound technology for triage of palpable breast lumps, an analysis of the anatomy of the breast ductal system and an investigation into the microbiome of the breast ducts. She received her medical degree from SUNY Downstate Medical Center in New York. She trained at Boston’s Beth Israel Hospital, was an early member of the Multidisciplinary Breast Center at the Dana–Farber Cancer Institute and founded the Brigham and Women’s Faulkner Breast Center and the Revlon/UCLA Breast Center. She received her business degree from the Executive MBA program at UCLA’s Anderson School of Management.
Emerging Applications for Big Data and AI in Health IT: Health care organizations are embracing the power of big data analytics and bulking up their health information technology (IT) structures. This panel will examine the novel ways in which big data and artificial intelligence (AI) are being used to improve clinical research, population health management, patient engagement and care coordination. Our panelists will share their insights from the perspectives of biopharma, providers and innovators.
Entrepreneurship in Health Care: Technology and innovation have always created a natural intersection between health care and entrepreneurship. However, the complexities of the industry can result in a difficult road. This panel will discuss some of the issues startups face that make the industry unique and explore what makes these challenges enticing to aspiring health care entrepreneurs.
Social Impact in Health Care: As health care advancements continue to occur at a rapid pace, misalignment between patient and provider needs as well as the disparity in access to health care remain ever-increasing challenges. This panel will explore the intersection of health care and social innovation, and how it is positively reforming the patient experience and addressing unmet needs.
Consumerism in Health Care: Traditional, consumer-oriented companies are moving into the health care sector, building on their existing modes of distribution. Additionally, a range of startups are creating new use cases for patient care delivery. Join us as we discuss these developments with a panel of leaders in telemedicine, mobile health and healthcare navigators. Topics will include evolving use cases for patient-centered care delivery and how consumerism is informing this sector.
Private Capital in Health Care: From seed funding to series A through C funding to private equity transactions, private capital is playing an ever-growing role in shaping the future of health care. This panel will feature California-based executives who will provide insight into West Coast opportunities, the pulse on the current health care market and an outlook for future investments in health care, ranging from retail health and pharmaceuticals to digital health and provider clinic acquisitions.